삼성서울병원

Ko En

Radiation Oncology Ahn, Yong Chan M.D

Expertise
Head/Neck Oncology , Thoracic Oncology (Lung cancer, Esophageal cancer, Mediastinal tumor), Stomach Cancer , Lymphoma, Sarcoma
Treament Schedule 06 月
DATE
THU
01
FRI
02
SAT
03
SUN
04
MON
05
TUE
06
WEB
07
THU
08
FRI
09
SAT
10
SUN
11
MON
12
TUE
13
WEB
14
THU
15
FRI
16
SAT
17
SUN
18
MON
19
TUE
20
WEB
21
THU
22
FRI
23
SAT
24
SUN
25
MON
26
TUE
27
WEB
28
THU
29
FRI
30
AM
PM
Treament Schedule 07 月
DATE
SAT
01
SUN
02
MON
03
TUE
04
WEB
05
THU
06
FRI
07
SAT
08
SUN
09
MON
10
TUE
11
WEB
12
THU
13
FRI
14
SAT
15
SUN
16
MON
17
TUE
18
WEB
19
THU
20
FRI
21
SAT
22
SUN
23
MON
24
TUE
25
WEB
26
THU
27
FRI
28
SAT
29
SUN
30
MON
31
AM
PM

Professional Appointments

2003. 08 ~ 2003. 10: Visiting Professor, Hokkaido University Medical School

Medical Education

Seoul National University College of Medicine

Post-Graduate Training

Fellowship   1992. 08 ~ 1993. 06: Research Fellow, Roswell Park Cancer Institute, USA
1993. 07 ~ 1994. 04: Clinical Fellow, British Columbia Cancer Agency, Canada
Residency   1989. 05 ~ 1992. 02: Seoul National University Hospital
Internship   1984. 03 ~ 1985. 02: Seoul National University Hospital

Professional Appointments

2003. 08 ~ 2003. 10: Visiting Professor, Hokkaido University Medical School

Professional Memberships

Domestic:
2001. 01 ~ Director, The Korean Lung Cancer Study Group
2004. 07 ~ Director, Korean Cancer Association
2004. 10 ~ 2007. 09: Director of General Affairs and Treasury, Korean Society for Therapeutic Radiology and Oncology
2007. 10 ~ Director of Board Qualifying Examination, Korean Society for Therapeutic Radiology and Oncology
2008. 10 ~ Vice-Editor-in-Chief, Korean Cancer Association
2008. 11 ~ Director of Public Relation, Korean Society for Head & Neck Oncology

International Membership:
American Society for Therapeutic Radiology and Oncology (ASTRO)
European Society for Therapeutic Radiology and Oncology (ESTRO)

Selected Publications

  • J BONE ONCOL 2021 10.1016/j.jbo.2021.100368 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
    View PubMed
  • CANCERS 2021 10.3390/cancers13071549 Early Clinical Outcomes of Intensity Modulated Radiation Therapy/Intensity Modulated Proton Therapy Combination in Comparison with Intensity Modulated Radiation Therapy Alone in Oropharynx Cancer Patients Yoon1, HG; Ahn, YC; Oh, D; Noh, JM; Park, SG; Nam, H; Ju, SG; Kwon, D; Park, S
    View PubMed
  • CANCERS 2021 10.3390/cancers13081913 Prognostic Value of the Neutrophil-to-Lymphocyte Ratio before and after Radiotherapy for Anaplastic Thyroid Carcinoma Park1, J; Park, J; Shin, JH; Oh, YL; Jung, HA; Chung, MK; Choe, JH; Ahn, YC; Kim, SW; Chung, JH; Kim, TH; Noh, JM
    View PubMed
  • ORAL ONCOL 2021 10.1016/j.oraloncology.2021.105180 Clinical features of post-radiation nasopharyngeal necrosis and their outcomes following surgical intervention in nasopharyngeal cancer patients Yang1, K; Ahn, YC; Nam, H; Hong, SD; Oh, D; Noh, JM
    View PubMed
  • KOREAN J INTERN MED 2021 10.3904/kjim.2019.161 Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer Lim1, SH; Sun, JM; Hong, J; Oh, D; Ahn, YC; Chung, MK; Jeong, HS; Son, YI; Ahn, MJ; Baek, CH; Park, K
    View PubMed